C1869891_interactsWith_C0286227 | Knowledge4COVID-19

Property	Value
?:effect	<https://research.tib.eu/covid-19/entity/C0001688>
?:hasPrimarySource	<https://research.tib.eu/covid-19/SourceName/UMLS>
?:impact	increase
?:interaction	The risk or severity of adverse effects can be increased when YKP-1358 is combined with Deramciclane.
?:objectDrug	<https://research.tib.eu/covid-19/entity/C0286227>
?:object_hasDrugBankID	<https://research.tib.eu/covid-19/entity/DB06512>
?:precipitantDrug	<https://research.tib.eu/covid-19/entity/C1869891>
?:precipitant_hasDrugBankID	<https://research.tib.eu/covid-19/entity/DB06109>
is ?:subClassOf of	<https://research.tib.eu/covid-19/entity/C1869891_hasPharmacodynamic_C0286227>
?:type	<https://research.tib.eu/covid-19/vocab/DrugDrugInteraction>

Metadata

Anon_0

expand all